Gene-based vaccines

Molecular Therapy

Volumn 1, Issue 6, 2000, Pages 497-500

  Liu, Margaret A ^a   Ulmer, Jeffrey B ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE;

ANIMAL; ANTIBODY PRODUCTION; GENE EXPRESSION; GENE THERAPY; GENETICS; HISTORY; HUMAN; IMMUNOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; GENE EXPRESSION; GENE THERAPY; HISTORY, 20TH CENTURY; HUMANS; T-LYMPHOCYTES; VACCINES, DNA;

EID: 0034200479     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0079     Document Type: Review

References (44)

1. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Felgner, P. L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
2. Israel, M. A., Chan, H. W., Hourihan, S. L., Rowe, W. P., and Martin, M. A. (1979). Biological activity of polyoma viral DNA in mice and hamsters. J. Virol. 29: 990-996.
3. Will, H., Cattaneo, R., Koch, H.-G., Daral, G., and Schaller, H. (1982). Cloned HBV DNA causes hepatitis in chimpanzees. Nature 299: 740-742.
4. Fung, Y.-K. T., Crittendon, L. B., Fadly, A. M., and Kung, H.-J. (1983). Tumor induction by direct injection of cloned v-src DNA into chickens. Proc. Natl. Acad. Sci. USA 80: 353-357.
5. Nicolau, C., Le Pape, A., Soriano, P., Fargette, F., and Juhel, M.-F. (1983). In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl. Acad. Sci. USA 80: 1068-1072.
6. Seeger, C., Gaben, D., and Varmus, H. E. (1984). The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc. Natl. Acad. Sci. USA 81: 5849-5852.
7. Bouchard, L., Gelinas, C., Asselin, C., and Bastin, M. (1984). Tumorigenic activity of polyoma virus and SV40 DNAs in newborn rodents. Virology 135: 53-64.
8. Dubensky, T. W., Campbell, B. A., and Villarreal, L. P. (1984). Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc. Natl. Acad. Sci. USA 81: 7529-7533.
9. Benvenisty, N., and Reshef, L. (1986). Direct introduction of genes into rats and expression of the genes. Proc. Natl. Acad. Sci. USA 83: 9551-9555.
10. Tang, D. C., Devit, M., and Johnston, S. A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152-154.
11. Ulmer, J. B., et al. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749.
12. Manthorpe, M., et al. (1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4: 419-431.
13. Fields, R. C., Shimizu, K., and Mulé, J. J. (1998). Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487.
14. Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996). Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184: 1555-1560.
15. Fu, T. M., et al. (1997). Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3: 362-371.
16. Iwasaki, A., Torres, C. A., Ohashi, P. S., Robinson, H. L., and Barber, B. H. (1997). The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159: 1-4.
17. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2: 1122-1228.
18. Chattergoon, M. A., Robinson, T. M., Boyer, J. D., and Weiner, D. B. (1998). Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160: 5707-5718.
19. Akbari, O., et al. (1999). DNA vaccination: Transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189: 169-177.
20. Bouloc, A., Walker, P., Grivel, J.-C., Vogel, J. C., and Katz, S. I. (1999). Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells. Eur. J. Immunol. 29: 446-454.
21. Ulmer, J. B., Deck, R. R., DeWitt, C. M., Donnelly, J. J., and Liu, M. A. (1996). Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells. Immunology 89: 59-67.
22. Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93: 8578-8583.
23. Corr, M., von Damm, A., Lee, D. J., and Tighe, H. (1999). In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. 163: 4721-4727.
24. Porgador, A., et al. (1998). Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188: 1075-1082.
25. Tokunaga, T., et al. (1984). Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72: 955-962.
26. Yamamoto, S., et at. (1992). Unique palindromic sequences in synthetic oligonucleotides are required to induce TNF and augment TNF-mediated natural killer activity. J. Immunol. 148: 4072-4076.
27. Messina, J. P., Gilkeson, G. S., and Pisetsky, D. S. (1991). Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147: 1759-1764.
28. Krieg, A. M., et al. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
29. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., and Krieg, A. M. (1996). CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 2879-2883.
30. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., and Vogel, J. C. (1998). Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161: 3042-3049.
31. Barry, M. E., et al. (1999). Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther. 10: 2461-2680.
32. Sato, Y., et al. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
33. Krieg, A. M., et al. (1998). Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95: 12631 -12636.
34. Donnelly, J. J., Ulmer, J. B., Shiver, J. W., and Liu, M. A. (1997). DNA vaccines. Annu. Rev. Immunol. 15: 617-648.
35. MacGregor, R., et al. (1998). First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. J. Infect. Dis. 178, 92-100.
36. Wang, R., et al. (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282: 476-480.
37. Calarota, S., et al. (1998). Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351, 1320-1325.
38. Calarota, S. A., et al. (1999). Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment. J. Immunol. 162: 2330-2338.
39. Boyer, J. D., et al. (1999). Enhancement of cellular immune responses in HIV-1 seropositive individuals: A DNA-based trial. Clin. Immunol. 90: 100-107.
40. Boyer, J. D., et al. (2000). Vaccination of seronegative volunteers with a human immunodeficiency virus type I env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines. J. Infect. Dis. 181: 476-483.
41. Tacket, C. O., et al. (1999). Phase I safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 17: 2826-2829.
42. Singh, M., Briones, M., Ott, G., and O'Hagan, D. (2000). Cationic microparticles: A potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. USA 97: 811-816.
43. Widera, G., et al. (2000). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164: 4635-4640.
44. Dubensky, T. W., et al. (1996). Sindbis virus DNA-based expression vectors: Utility for in vitro and in vivo gene transfer. J. Virol. 70: 508-514.